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ABSTRACT
The efficacy and toxicity of four commonly used antimalarials was evaluated. The 
combinations evaluated were Artesunate and Doxycycline, Quinine and Doxycycline, Artesunate 
and Quinine, Artesunate and Mefloquine. The four combinations did not show any statistically 
significant difference in terms of days of defervescence, parasite clearance and hospital stay. All 
the four combinations were well tolerated.
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INTRODUCTION
Malaria is one of the most important infectious diseases causing hundreds of millions of 
illnesses and an estimated 1 million deaths each year1. Nearly all serious illnesses and deaths 
from malaria are caused by Plasmodium falciparum. There are almost 515 million episodes of 
clinical Plasmodium falciparum malaria infections2.The incidence of malaria was 0.46 million in 
2006 and there were about 890 deaths that year3. The treatment of malaria is highly effective if 
provided rapidly, used correctly and is not limited by drug resistance4. Antimalarials
combination therapy is currently regarded as a major strategy to combat drug-resistant malaria. 
Combination therapy involves the simultaneous use of two or more blood schizonticides that 
have independent modes of action and different biochemical targets in the parasite5. The 
combination of artemisinin derivatives with other antimalarial drugs is widely advocated because 
it produces rapid clinical and parasitological response, may delay the development of resistance, 
and may reduce malaria transmission5. Different antimalarial regimens are being used for 
treatment of falciparum malaria in different centers. Each one of these combination has its own 
advantages and disadvantages. In this study we have compared the efficacy and toxicity of 
different regimens used in our tertiary care hospital.
MATERIALS AND METHODS
This was a retrospective study. The study was approved by institutional ethics committee 
and permission to access the data was given. Data was collected from medical records 
department of the in-patients diagnosed as Plasmodium falciparum malaria in the year 2006-
2007. Efficacy was measured in terms of number of days for: parasite clearance, defervescence, 
hospital stay. Parasitological diagnosis was made by light microscopy and rapid diagnostic tests. 
Body temperature was recorded six hourly. Defervecence days gave the time in which patient 
became afebrile. The number of days patient stayed in hospital was also recorded .Toxicity was 
assessed by monitoring the adverse events in patients as per their clinical symptoms. Adverse 
events secondary to antimalarial drugs in the patient’s record was noted.
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RESULTS
A total of 100 prescriptions of in-patients were evaluated, of which 79 were of males and 
21 of females. Prescriptions of patients diagnosed as P. falciparum malaria were included in the
study. Prescriptions were analyzed as per the performa which included patient particulars, 
complete diagnosis, the drugs used along with their dosage, formulation and duration of use .The 
commonly used antimalarial combinations were Artesunate + Doxycycline (Art+Doxy),
Quinine+Doxycycline (Quinine+Doxy), Artesunate + Quinine(Art+Quinine), Artesunate + 
Mefloquine (Art+Mef) and others. The percentage of patients prescribed these combinations is 
























*after initial loading dose                  #shifting the drug from i.v to oral
TABLE 1. Showing the dosage schedule and duration of treatment
The dosage schedule of different combinations is shown in Table 1. The hospital stay days 
and the days required for smear conversion  is shown in Fig.2.The mean of hospital stay days 
was from 7.0 to 9.0 days and there was statistically no difference between the four groups (P= 
0.15). 5.6-7 days were required for smear conversion in the four groups (P= 0.15). The days for 
defervescence i.e the days patient took to become afebrile were 3.15 to 4.4 days and the 
difference between the four groups was insignificant (P=0.21) as shown in Fig.3.Six patients did 
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not respond to treatment. Two of these had other complications and died. Three patients had 
history of relapse and one left against medical advice. Two patients in quinine groups developed 
ototoxic manifestations secondary to quinine. One patient had tinnitus and the other patient had 
tinnitus in addition to difficulty in hearing. Both the patients developed these adverse effects 
after three days of quinine treatment and the symptoms abated after quinine was stopped. One 
patient on Mefloquine developed anemia and hemoglobin dropped from 11.6mg/dl to 5.3mg/dl.
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All the efficacy parameters did not show any statistically significant difference among the 
four groups. But from the graphs of smear conversion and hospital stay days artemisinin 
combinations appear superior to quinine combinations. The superiority of Artemisinin is due to 
its rapid action against all the erythrocytic stages of the parasite and a limited resistance6.
As per the WHO guidelines Artesunate and mefloquine is one of the first line combination used 
in Plasmodium falciparum malaria7.Though Artemisinin  and Doxycycline is the second line 
combination as per the WHO guidelines7 but the physicians are justified in using it as first line as 
it is equally efficacious and well tolerated as compared to Artesunate and mefloquine in this 
study. Artemisinin and Doxycycline  combination has the  advantage of simplicity and 
coformulation which improves adherence7. Quinine and doxycycline is not well tolerated and 
adherence is poor if the treatment is not observed7.In patients with malaria, anemia results from 
accelerated RBC removal by the spleen, obligatory RBC destruction at parasite schizogony, and 
ineffective erythropoiesis. In severe malaria, both infected and uninfected RBCs show reduced 
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deformability, which correlates with prognosis and development of anemia. Two patients in Art 
+ mefloquine developed anemia three days after the drug administration. 
It cannot be solely attributed to drug as disease progression can also lead to anemia. One 
patient with quinine developed tinnitus and other complained of tinnitus with difficulty in 
hearing. Quinine causes functional impairment of eighth nerve leading to tinnitus and decreased 
auditory acuity8. The four regimens used to treat Plasmodium falciparum malaria did not differ 
significantly with regard to days of defervescence, hospital stay and smear conversion. Most of 
the patients tolerated all the four regimens well.
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